A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors

Nephron - Clinical Practice

Volumn 97, Issue 2, 2004, Pages

  Prasad, G V Ramesh ^a   Nash, Michelle M ^a   McFarlane, Philip A ^a   Zaltzman, Jeffrey S ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Calcineurin inhibitors, questionnaire; Cyclosporine; Immunosuppressive therapy, side effects; Likert scale; Renal transplant recipient experience, survey; Renal transplantation; Tacrolimus

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTHROPATHY; ARTICLE; BLOOD DISEASE; BLOOD DYSCRASIA; BONE DISEASE; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EXPERIENCE; FEMALE; GRAFT REJECTION; HAIR DISEASE; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; RECIPIENT; SIDE EFFECT; SKIN DISEASE; STOMACH DISEASE; SWALLOWING; TREMOR; WATER RETENTION; WEIGHT GAIN;

ADULT; ATTITUDE TO HEALTH; CALCINEURIN; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK; TACROLIMUS; THERAPEUTIC EQUIVALENCY; TREATMENT REFUSAL;

EID: 3042594715     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078398     Document Type: Article

References (15)

1. Reimer J, Franke GH, Philipp T, Heemann U: Quality of life in kidney recipients: Comparison of tacrolimus and cyclosporine microemulsion. Clin Transplant 2002;16:48.
2. Shield CF III, McGrath MM, Goss TF: Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group. Transplantation 1997;64:1738.
3. Rebollo P, Ortega F, Baltar JM, Badia X, Alvarez-Ude F, Diaz-Corte C, Naves M, Navascues RA, Urena A, Alvarez-Grande J: Health-related quality of life (HRQOL) of kidney transplanted patients: Variables that influence it. Clin Transplant 2000;14:199.
4. Von Steinbuchel N, Limm H, Leopold C, Carr D: Assessment of health-related quality-of-life in patients after heart transplantation under therapy with tacrolimus or cyclosporine. Transpl Int 2000;13(suppl 1):609.
5. Groetzner J, Meiser BM, Schirmer J, Koglin J, Scheidt W, Klauss V, Cremer P, Reichenspurner H, Reichart B: Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: Which treatment reveals more side effects during long-term follow-up? Transplant Proc 2001;33:1461.
6. Moons P, De Geest S, Abraham I, Van Cleemput J, Vanhaecke J: Symptom experience associated with maintenance immunosuppression after heart transplantation: Patients' appraisal of side effects. Heart Lung 1998;27:315.
7. De Geest S, Moons P: The patient's appraisal of side-effects: The blind spot in quality-of-life assessments in transplant recipients. Nephrol Dial Transplant 2000;15:457.
8. Prasad GVR, Nash MM, McFarlane PA, Zaltzman JS: Renal transplant recipient attitudes toward steroid use and steroid withdrawal. Clin Transplant 2003;17:135.
9. Likert RA: A technique for the development of attitude scales. Educ Psychol Meas 1952;12:313.
10. Sundberg AK, Smith LD, Somerville KT, Cox R, Sherbotie JR: Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: A focus on opinions and outcomes. Transplant Proc 2002;34:1951.
11. Spiro SE, Shalev A, Solomon Z, Kotler M: Self-reported change versus changed self-report: Contradictory findings of an evaluation of a treatment program for war veterans suffering from post-traumatic stress disorder. Eval Rev 1989;15:533.
12. Hilbrands LB, Hoitsma AJ, Koene RA: The effect of immunosuppressive drugs on quality of life after renal transplantation. Transplantation 1995;59:1263.
13. Trevitt R, Smitherman R, Fitzgerald L, Whittaker C, Ball EA: Internet use by patients - A shift in power? EDTNA ERCA J 2001;27:28.
14. Villanueva P, Peiro S, Librero J, Pereiro I: Accuracy of pharmaceutical advertisements in medical journals. Lancet 2003;361:27.
15. First MR, Peters T, West J, Aeder M, Danovitch G, Gorman K, Gordon J, Spinola K: Differences in patient and healthcare provider perceptions of immunosuppression-induced physical side effects. Am J Transplant 2002;2(suppl 3):404, A1057.